Hutchmed (china) Share Discussion Threads

[protean] 15/4/2013 09:50

Price had gone sideways for about a year so probably some pent up demand when everyone saw it starting to trend upwards again.

[dlku] 15/4/2013 09:37

Going mental

[daveycaferacer] 12/4/2013 20:01

Maybe they will raise again the potential to float the Drug division on NASDAQ. It's been discussed before and wasn't dismissed out of hand when I asked the question at last years AGM..... or maybe something else is going on

[protean] 12/4/2013 16:04

Price is still only where it was in Nov 2010 yet prospects looking very good.

The strong rise from late 2008 to late 2010 shows how powerfully this can trend when it gets going.

[snatander] 12/4/2013 12:50

You can say that again

[snatander] 12/4/2013 12:50

You can say that again

[snatander] 12/4/2013 12:50

You can say that again

[snatander] 12/4/2013 12:50

You can say that again

[protean] 12/4/2013 09:14

Building up some momentum now.

[snatander] 12/4/2013 07:55

maybe will now go to broker target of 800p

[gbb483] 11/4/2013 21:22

The financials page gives HCM a PE in excess of 100 - can this be right?

[protean] 09/4/2013 07:34

From the 2012 Annual Report on the company website today:



"Current Trading and Outlook for the Group

We believe that 2013 will be a very good year for Chi-Med across all three divisions. Sales and profit in the China Healthcare Division has started the year well ahead of 2012 levels as a result of effective commercial execution and a continued normalisation of certain raw material prices. We also expect to create considerable value through our plans to relocate and expand our China
manufacturing during the year.

In the Drug R&D Division, we will continue to progress our broad pipeline of drugs in the clinic, thereby further proving their efficacy and safety and potentially leading to a rapid increase in their market value through milestone payments from existing partners and/or further licensing and collaboration activity. Through NSP, our joint venture with Nestlé Health Science, we are also now ready to start the global Phase III trial on HMPL-004.

The Consumer Products Division continuing operations have started the year well and we expect with our focus on HHO and the Division's continuing operations will be operating cash neutral in 2013.

We look forward to 2013 with the expectation of making continued great strides forward on all Chi-Med's businesses."

[snatander] 08/4/2013 16:09

every chinese tod is gonna be drinking good milk
they only have one kid allowed each so will be happy to pay top dollar

[protean] 08/4/2013 16:03

"Through our close partnership with Hain Celestial over the past two years, we have created what we believe to be one of the most premium infant formula products available on the China market. We believe the scope to build sales and market share is considerable."

[protean] 08/4/2013 15:53

Interesting story today about the rationing of baby milk because of a surge in demand for foreign-made baby milk in China.








Such demand for foreign-made baby milk could be good news for HCM since they manufacture theirs in Switzerland.

[protean] 08/4/2013 15:01

Looks like the price is breaking above the year long sideways consolidation so there is the potential for a new uptrend to develop here.

This is the biggest holding in the successful Slater Growth fund and Slater rates it for 2013 as a good growth pick.



A lot of optimism from the CEO recently saying "We expect to create substantial shareholder value in 2013/2014 and the years beyond." That's pretty bullish imo.

[gbb483] 03/4/2013 22:08

Post 508 seems to have gone walkabout - which mucks up the 'messages unread' counter.

[protean] 26/3/2013 15:37

The chart has certainly gone sideways for a good long while paleje but Slater has kept faith whilst price went nowhere.

The tone of today's RNS is very upbeat and the CEO must certainly see a strong future when he says that he expects to "create substantial shareholder value in 2013/2014 and the years beyond". You don't say that sort of thing unless you're very confident about prospects.

For now price is breaking out of a wide sideways base and if it can continue with this move then this will bring in momentum traders and help create a new uptrend imo.

[paleje] 26/3/2013 15:31

They (not necessarily Slater) were looking for £10 per share on a 5 year view 3 years ago, Protean:)

Not knocking it though, I hold, thought the RNS today was very good, always seems to take the market a while to respond to these guys, not a bad thing, better than spiking. Thanks for the link.

[protean] 26/3/2013 14:56

'Another company I like very much is Hutchinson China. Its Chinese healthcare division sells prescription and non-prescription Chinese medicines and is supported by a big salesforce and strong branding. Some of their drugs are even on the essential-medicines list in China which, given massive government spending on healthcare, gives the company a wonderful tail-wind.

'In addition, the company's separate R&D operation is loaded with intellectual property which is being commercialised with partners like AstraZeneca and Nestle. The healthcare division alone is worth more than the market capitalisation leaving the R&D operation, cash and consumer products division in for nothing. On a five year view, the stock could hit £10 a share.